PI
TGTX icon

PFG Investments’s TG Therapeutics TGTX Stock Holding History

PFG Investments’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Sell
6,019
-500
-8% -$20.5K 0.01% 886
2026
Q1 		$217K Sell
6,519
-2,000
-23% -$59.6K 0.01% 1032
2025
Q4 		$254K Buy
+8,519
New +$278K 0.01% 900

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

PFG Investments's TGTX Position: Q2 2026 in Review

PFG Investments reduced its TG Therapeutics (TGTX) stake by 7.7% in Q2 2026, selling an estimated $20.5K and leaving 6,019 shares worth $331K. The position accounts for 0.01% of the portfolio, ranked #886.

PFG Investments first reported a position in TGTX in Q4 2025 and has held it in 3 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • PFG Investments held 6,019 shares of TG Therapeutics worth $331K as of Q2 2026.
  • PFG Investments sold 500 TG Therapeutics shares in Q2 2026, an estimated $20.5K.
  • TG Therapeutics made up 0.01% of PFG Investments's portfolio in Q2 2026, its #886 holding.
  • PFG Investments first reported a position in TG Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.